GLP1R and chronic kidney disease: Several direct MoAs have been proposed for GLP-1R-mediated kidney protection in CKD, including suppression of kidney inflammation and oxidative stress, induction of natriuresis and improved glomerular haemodynamics and perfusion (Fig. 1).